Developmental pharmacokinetics in neonates

Area of Science:

• Pharmacology
• Neonatal Medicine
• Drug Metabolism

Background:

• Neonatal drug administration requires understanding developmental drug disposition.
• Significant interindividual variability exists in drug disposition among neonates.
• Renal and metabolic clearance pathways are immature in neonates, impacting drug elimination.

Purpose of the Study:

• To review the developmental aspects of drug disposition in neonates.
• To highlight factors contributing to interindividual variability in neonatal drug clearance.
• To discuss clinical research tools for assessing maturational changes in drug disposition.

Main Methods:

• Review of existing clinical research and literature on neonatal drug disposition.
• Analysis of factors influencing drug clearance, including age, route of administration, and genetics.
• Discussion of population pharmacokinetic approaches.

Main Results:

• Renal drug elimination is decreased due to immature renal function.
• Metabolic clearance is dependent on specific enzyme ontogeny and postmenstrual/postnatal age.
• Age, route of administration, comorbidities, co-administered drugs, and genetic polymorphisms contribute to variability.

Conclusions:

• Integrating knowledge of neonatal drug disposition into clinical practice is essential for safe prescribing.
• Legal initiatives like the EU's Paediatric Drug Regulation and research tools like population pharmacokinetics are key drivers for progress.
• Further research and clinical integration are needed to optimize neonatal pharmacotherapy.